Matinas BioPharma (MTNB)

• Market cap: $4.03M
• 1 day: 2.86%
• 5 days: -4.62%
• 1 month: -27.81%
• 3 months: 14.45%
• 6 months: 1.53%
• Year to date: 1.53%
• 1 year: -30.3%
• 5 years: -98.39%
• 10 years: -99.67%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

Employees: 2